These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38453453)

  • 1. Adherence to a restrictive red blood cell transfusion strategy in critically ill patients: An observational study.
    Bjurström MF; Linder YC; Kjeldsen-Kragh J; Bengtsson J; Kander T
    Acta Anaesthesiol Scand; 2024 Jul; 68(6):812-820. PubMed ID: 38453453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion thresholds for guiding red blood cell transfusion.
    Carson JL; Stanworth SJ; Dennis JA; Trivella M; Roubinian N; Fergusson DA; Triulzi D; Dorée C; Hébert PC
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD002042. PubMed ID: 34932836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Radford M; Estcourt LJ; Sirotich E; Pitre T; Britto J; Watson M; Brunskill SJ; Fergusson DA; Dorée C; Arnold DM
    Cochrane Database Syst Rev; 2024 May; 5(5):CD011305. PubMed ID: 38780066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
    Carson JL; Stanworth SJ; Roubinian N; Fergusson DA; Triulzi D; Doree C; Hebert PC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002042. PubMed ID: 27731885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.
    Jairath V; Kahan BC; Gray A; Doré CJ; Mora A; James MW; Stanley AJ; Everett SM; Bailey AA; Dallal H; Greenaway J; Le Jeune I; Darwent M; Church N; Reckless I; Hodge R; Dyer C; Meredith S; Llewelyn C; Palmer KR; Logan RF; Travis SP; Walsh TS; Murphy MF
    Lancet; 2015 Jul; 386(9989):137-44. PubMed ID: 25956718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemoglobin values, transfusion practices, and long-term outcomes in critically ill patients with traumatic brain injury: a secondary analysis of CENTER-TBI.
    Guglielmi A; Graziano F; Bogossian EG; Turgeon AF; Taccone FS; Citerio G;
    Crit Care; 2024 Jun; 28(1):199. PubMed ID: 38877571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.
    Tay J; Allan DS; Chatelain E; Coyle D; Elemary M; Fulford A; Petrcich W; Ramsay T; Walker I; Xenocostas A; Tinmouth A; Fergusson D
    J Clin Oncol; 2020 May; 38(13):1463-1473. PubMed ID: 32083994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
    Hébert PC; Yetisir E; Martin C; Blajchman MA; Wells G; Marshall J; Tweeddale M; Pagliarello G; Schweitzer I;
    Crit Care Med; 2001 Feb; 29(2):227-34. PubMed ID: 11246298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell transfusion practice following the transfusion requirements in critical care (TRICC) study: prospective observational cohort study in a large UK intensive care unit.
    Chohan SS; McArdle F; McClelland DB; Mackenzie SJ; Walsh TS
    Vox Sang; 2003 Apr; 84(3):211-8. PubMed ID: 12670370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial.
    Walsh TS; Boyd JA; Watson D; Hope D; Lewis S; Krishan A; Forbes JF; Ramsay P; Pearse R; Wallis C; Cairns C; Cole S; Wyncoll D;
    Crit Care Med; 2013 Oct; 41(10):2354-63. PubMed ID: 23939351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is haemoglobin below 7.0 g/dL an optimal trigger for allogenic red blood cell transfusion in patients admitted to intensive care units? A meta-analysis and systematic review.
    Yao RQ; Ren C; Zhang ZC; Zhu YB; Xia ZF; Yao YM
    BMJ Open; 2020 Feb; 10(2):e030854. PubMed ID: 32029484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023.
    Houben NAM; Fustolo-Gunnink S; Fijnvandraat K; Caram-Deelder C; Carrascosa MA; Beuchée A; Brække K; Cardona F; Debeer A; Domingues S; Ghirardello S; Grizelj R; Hadžimuratovic E; Heiring C; Krivec JL; Malý J; Matasova K; Moore CM; Muehlbacher T; Szabó M; Szczapa T; Zaharie G; de Jager J; Reibel-Georgi NJ; New HV; Stanworth SJ; Deschmann E; Roehr CC; Dame C; le Cessie S; van der Bom J; Lopriore E;
    JAMA Netw Open; 2024 Sep; 7(9):e2434077. PubMed ID: 39298172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.
    Gu Y; Estcourt LJ; Doree C; Hopewell S; Vyas P
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011577. PubMed ID: 26436602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomized Controlled Trial.
    Bergamin FS; Almeida JP; Landoni G; Galas FRBG; Fukushima JT; Fominskiy E; Park CHL; Osawa EA; Diz MPE; Oliveira GQ; Franco RA; Nakamura RE; Almeida EM; Abdala E; Freire MP; Filho RK; Auler JOC; Hajjar LA
    Crit Care Med; 2017 May; 45(5):766-773. PubMed ID: 28240687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion strategies for patients in pediatric intensive care units.
    Lacroix J; Hébert PC; Hutchison JS; Hume HA; Tucci M; Ducruet T; Gauvin F; Collet JP; Toledano BJ; Robillard P; Joffe A; Biarent D; Meert K; Peters MJ; ; ;
    N Engl J Med; 2007 Apr; 356(16):1609-19. PubMed ID: 17442904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the red blood cell transfusion threshold from 8·0 g/dl to 7·0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome.
    Ballo O; Fleckenstein P; Eladly F; Kreisel EM; Stratmann J; Seifried E; Müller M; Serve H; Bug G; Bonig H; Brandts CH; Finkelmeier F
    Vox Sang; 2020 Oct; 115(7):570-578. PubMed ID: 32342521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group.
    Hébert PC; Wells G; Marshall J; Martin C; Tweeddale M; Pagliarello G; Blajchman M
    JAMA; 1995 May; 273(18):1439-44. PubMed ID: 7723158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines.
    Walsh TS; Garrioch M; Maciver C; Lee RJ; MacKirdy F; McClelland DB; Kinsella J; Wallis C;
    Transfusion; 2004 Oct; 44(10):1405-11. PubMed ID: 15383011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.